20-F Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 FY 2020

Filing Information

Form Type	20-F
Accession Number	`0001213900-21-017883`
Period End Date	20201231
Filing Date	20210326
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	clgn-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 41 Cash Flow Statement 101 Stockholders Equity 30

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares par value (in New Shekels per share)	`CommonStockParOrStatedValuePerShare`	1.50	ILS	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.35M	USD	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`CommonStockSharesAuthorized`	30.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.79M	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesOutstanding`	6.96M	shares	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositCurrent`	$12.00K	USD	Point-in-time
Ordinary shares, shares issued	`CommonStockSharesOutstanding`	5.67M	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$79.00K	USD	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesIssued`	5.67M	shares	Point-in-time
Ordinary shares, shares outstanding	`CommonStockSharesIssued`	6.96M	shares	Point-in-time
Trade receivables	`AccountsReceivableNetCurrent`	$830.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$239.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`PrepaidExpenseAndOtherAssetsCurrent`	$270.00K	USD	Point-in-time
Inventory	`InventoryNet`	$888.00K	USD	Point-in-time
Inventory	`InventoryNet`	$1.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.68M	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$168.00K	USD	Point-in-time
Restricted deposit	`RestrictedDepositNoncurrent`	$181.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$2.80M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.21M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.11M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.33M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$82.00K	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.17M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$5.71M	USD	Point-in-time
Total assets	`Assets`	$10.84M	USD	Point-in-time
Total assets	`Assets`	$10.75M	USD	Point-in-time
Current maturity of loan	`LoansPayableCurrent`	$24.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$833.00K	USD	Point-in-time
Trade payables	`AccountsPayableTradeCurrent`	$798.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$440.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$455.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$207.00K	USD	Point-in-time
Deferred revenues	`DeferredRevenues`	$942.00K	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.94M	USD	Point-in-time
Accrued liabilities and other	`AccruedLiabilitiesAndOtherLiabilities`	$1.20M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.46M	USD	Point-in-time
Derivatives liability	`DerivativeLiabilitiesNoncurrent`	$28.00K	USD	Point-in-time
Derivatives liability	`DerivativeLiabilitiesNoncurrent`	$68.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.95M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.14M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$2.98M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$3.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.66M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2020 and December 31, 2019; issued and outstanding: 6,963,838 and 5,670,829 ordinary shares as of December 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$2.37M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2020 and December 31, 2019; issued and outstanding: 6,963,838 and 5,670,829 ordinary shares as of December 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$2.93M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$75.55M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidInCapitalAndWarrants`	$69.95M	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Currency translation differences	`CurrencyTranslationDifferences`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-73.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-67.26M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$5.42M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$4.09M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$5.17M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$10.75M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$10.84M	USD	Point-in-time

Income Statement 41 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$2.32M	USD	Annual
Revenues	`Revenues`	$5.01M	USD	Annual
Revenues	`Revenues`	$6.14M	USD	Annual
Cost of revenues	`CostOfRevenue`	$3.00M	USD	Annual
Cost of revenues	`CostOfRevenue`	$1.66M	USD	Annual
Cost of revenues	`CostOfRevenue`	$1.88M	USD	Annual
Gross Profit	`GrossProfit`	$439.00K	USD	Annual
Gross Profit	`GrossProfit`	$3.13M	USD	Annual
Gross Profit	`GrossProfit`	$3.35M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$3.88M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$4.41M	USD	Annual
Research and development, net	`ResearchAndDevelopmentExpense`	$4.07M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.72M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$4.67M	USD	Annual
General, administrative and marketing	`GeneralAndAdministrativeExpense`	$3.66M	USD	Annual
Total operating loss	`OperatingIncomeLoss`	$-7.63M	USD	Annual
Total operating loss	`OperatingIncomeLoss`	$-5.60M	USD	Annual
Total operating loss	`OperatingIncomeLoss`	$-4.25M	USD	Annual
Financial expenses	`FinancialExpenses`	$3.30M	USD	Annual
Financial expenses	`FinancialExpenses`	$34.00K	USD	Annual
Financial expenses	`FinancialExpenses`	$2.18M	USD	Annual
Financial income	`InvestmentIncomeNonoperating`	$40.00K	USD	Annual
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$230.00K	USD	Annual
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$181.00K	USD	Annual
Exchange differences	`ForeignCurrencyTransactionLossBeforeTaxes`	$-176.00K	USD	Annual
Financial expenses, net	`InvestmentIncomeInvestmentExpense`	$175.00K	USD	Annual
Financial expenses, net	`InvestmentIncomeInvestmentExpense`	$2.00M	USD	Annual
Financial expenses, net	`InvestmentIncomeInvestmentExpense`	$3.53M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-5.77M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-11.16M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-6.25M	USD	Annual
Currency translation differences	`OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax`	$557.00K	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncomeNetOfTax`	$-11.16M	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncomeNetOfTax`	$-6.81M	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncomeNetOfTax`	$-5.77M	USD	Annual
Basic and diluted loss per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$0.84	USD	Annual
Basic and diluted loss per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$2.23	USD	Annual
Basic and diluted loss per ordinary share (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$1.43	USD	Annual
Weighted average number of shares outstanding used in computation of basic and diluted loss per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.99M	shares	Annual
Weighted average number of shares outstanding used in computation of basic and diluted loss per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.38M	shares	Annual
Weighted average number of shares outstanding used in computation of basic and diluted loss per share (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.89M	shares	Annual

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Net cash used in operations (see Appendix A)	`NetCashUsedInOperationsseeAppendixA`	$1.22M	USD	Annual
Net cash used in operations (see Appendix A)	`NetCashUsedInOperationsseeAppendixA`	$5.70M	USD	Annual
Net cash used in operations (see Appendix A)	`NetCashUsedInOperationsseeAppendixA`	$4.45M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.45M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.70M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$82.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.49M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$832.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$437.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$30.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-832.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-519.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.46M	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.78M	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$5.44M	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$4.40M	USD	Annual
Exercise of options into shares	`ProceedsFromWarrantExercises`	$7.00K	USD	Annual
Exercise of options into shares	`ProceedsFromWarrantExercises`	$89.00K	USD	Annual
Loan received	`ProceedsFromIssuanceOfDebt`	$58.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	$12.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	$24.00K	USD	Annual
Loan repaid	`RepaymentsOfDebt`	$20.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsMadeForEquipmentOnFinancingTerms`	$70.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsMadeForEquipmentOnFinancingTerms`	$17.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.75M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.46M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.41M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$704.00K	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.75M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-505.00K	USD	Annual
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.28M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-325.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-62.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$60.00K	USD	Annual
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.28M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time
Loss	`NetIncomeLoss`	$-5.77M	USD	Annual
Loss	`NetIncomeLoss`	$-11.16M	USD	Annual
Loss	`NetIncomeLoss`	$-6.25M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$342.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$660.00K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$539.00K	USD	Annual
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$1.67M	USD	Annual
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$1.12M	USD	Annual
Share-based compensation to employees and consultants	`AllocatedShareBasedCompensationExpense`	$1.43M	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$184.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$62.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$60.00K	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$3.23M	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$2.29M	USD	Annual
Financial expenses (income) related to financial instruments	`FinancialExpensesRelatedToFinancialInstruments`	$-40.00K	USD	Annual
Net change of operating lease accounts	`OperatingLeaseExpense`	$213.00K	USD	Annual
Net change of operating lease accounts	`OperatingLeaseExpense`	$382.00K	USD	Annual
Total net cash used in operations	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	Annual
Total net cash used in operations	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-3.33M	USD	Annual
Total net cash used in operations	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$-5.95M	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$-437.00K	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$751.00K	USD	Annual
Decrease (increase) in trade receivables	`IncreaseDecreaseInAccountsReceivable`	$439.00K	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$653.00K	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$74.00K	USD	Annual
Increase in inventory	`IncreaseDecreaseInInventories`	$374.00K	USD	Annual
Decrease in other receivables	`IncreaseDecreaseInOtherReceivables`	$-220.00K	USD	Annual
Decrease in other receivables	`IncreaseDecreaseInOtherReceivables`	$-35.00K	USD	Annual
Decrease in other receivables	`IncreaseDecreaseInOtherReceivables`	$-31.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$228.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-112.00K	USD	Annual
Increase (decrease) in trade payables	`IncreaseDecreaseInAccountsPayableTrade`	$-35.00K	USD	Annual
Increase in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$629.00K	USD	Annual
Increase in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$99.00K	USD	Annual
Increase in accrued liabilities and other payables	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$740.00K	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-1.01M	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$2.03M	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredRevenue`	$-735.00K	USD	Annual
Total changes in operating asset and liability	`IncreaseDecreaseInOperatingCapital`	$1.15M	USD	Annual
Total changes in operating asset and liability	`IncreaseDecreaseInOperatingCapital`	$-247.00K	USD	Annual
Total changes in operating asset and liability	`IncreaseDecreaseInOperatingCapital`	$1.12M	USD	Annual
Net cash used in operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-1.22M	USD	Annual
Net cash used in operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-4.45M	USD	Annual
Net cash used in operations	`AdjustmentForNetCashProvidedByUsedInOperations`	$-5.70M	USD	Annual
Conversion of debentures to pre-paid warrants	`ConversionOfStockAmountIssued1`	$3.27M	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$22.00K	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$355.00K	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfStockAmountConverted1`	$68.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$23.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$97.00K	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	$2.02M	USD	Annual
Classification of warrants from liabilities to equity, net	`ProceedsFromIssuanceOfWarrants`	$1.33M	USD	Annual
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$309.00K	USD	Annual
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$180.00K	USD	Annual
Restricted deposits (including long term)	`RestrictedDepositsincludingLongTerm`	$193.00K	USD	Annual
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.97M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.28M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.66M	USD	Point-in-time
Total cash and cash equivalents and restricted deposits	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.53M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$50.00K	USD	Annual
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$100.00K	USD	Annual
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.42M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$4.40M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$7.37M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$2.78M	USD	Annual
Classification of warrants from equity to liability, see note 2c	`ClassificationOfWarrantsFromEquityToLiability`	$-1.80M	USD	Annual
Classification of warrants from liability to equity, see NOTE 9 - A(2)	`ClassificationOfWarrantsFromLiabilityToEquity`	$3.14M	USD	Annual
Conversion of debentures to prepaid warrants	`ConversionOfDebenturesToPrepaidWarrants`	$3.27M	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinarySharesValue`	-	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$7.00K	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$89.00K	USD	Annual
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00M	USD	Point-in-time
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$69.00K	USD	Annual
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$8.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.12M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.00M	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation`	$1.60M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-5.77M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-11.16M	USD	Annual
Loss for the period	`NetIncomeLoss`	$-6.25M	USD	Annual
Balance	`StockholdersEquity`	$4.48M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.42M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.09M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.